Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Biogen Inc Recent news which mentions Biogen Inc < Previous 1 2 3 Next > Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction August 01, 2024 Tags Pharmaceuticals Health & Science Earnings From CNBC.com News Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says July 30, 2024 Tags US: News Pharmaceuticals Health & Science From CNBC.com News Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says July 30, 2024 Tags US: News Eli Lilly and Co Novo Nordisk A/S From CNBC.com News European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai July 26, 2024 Tags Biogen Inc Business Health care industry From CNBC.com News Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug June 11, 2024 Tags Investing Eli Lilly and Co U/S/ Markets From CNBC.com News Cramer's Lightning Round: Bank of America is a buy May 10, 2024 Tags stocks Market Outlook Stock Picks From CNBC.com News Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up April 24, 2024 Tags Pharmaceuticals Health & Science US: News From CNBC.com News 5 things to know before the stock market opens Monday April 22, 2024 Tags PepsiCo Inc/ Ford Motor Co Bristol/Myers Squibb Co From CNBC.com News Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move March 08, 2024 Tags Eli Lilly and Co US: News Pharmaceuticals From CNBC.com News Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start February 20, 2024 Tags Science Eisai Co Ltd Biotech and Pharmaceuticals From CNBC.com News Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies February 13, 2024 Tags Pharmaceuticals Health & Science US: News From CNBC.com News 5 things to know before the stock market opens Monday February 12, 2024 Tags Politics PepsiCo Inc/ Verizon Communications Inc From CNBC.com News Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments January 31, 2024 Tags Business News Science Eisai Co Ltd From CNBC.com News Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma December 20, 2023 Tags Biotechnology Biotech and Pharmaceuticals Eisai Co Ltd From CNBC.com News 5 things to know before the stock market opens Monday November 06, 2023 Tags Warner Bros Discovery Inc Economy Lyft Inc From CNBC.com News More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study October 25, 2023 Tags Biotech and Pharmaceuticals Biotechnology Science From CNBC.com News Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug August 07, 2023 Tags Business News Biotech and Pharmaceuticals Biotechnology From CNBC.com News Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more July 28, 2023 Tags Mondelez International Inc AstraZeneca PLC stocks From CNBC.com News Stocks making the biggest moves midday: Spotify, RTX, General Electric and more July 25, 2023 Tags Business Spotify Technology SA General Motors Co From CNBC.com News Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch July 25, 2023 Tags Health care industry Business Biogen Inc From CNBC.com News 5 things to know before the stock market opens Tuesday July 18, 2023 Tags Investment strategy Technology Business From CNBC.com News Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year July 17, 2023 Tags Biotech and Pharmaceuticals Biotechnology Alzheimer's disease From CNBC.com News Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know July 08, 2023 Tags Alzheimer's disease Biotechnology Biotech and Pharmaceuticals From CNBC.com News Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024 July 07, 2023 Tags Companies Business Biogen Inc From CNBC.com News Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more July 07, 2023 Tags Biogen Inc Business Rivian Automotive Inc From CNBC.com News Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more July 07, 2023 Tags Business Biogen Inc Finance From CNBC.com News Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug July 07, 2023 Tags Asia Markets Pharmaceuticals Biogen Inc From CNBC.com News FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage July 06, 2023 Tags Biotech and Pharmaceuticals Alzheimer's disease Biotechnology From CNBC.com News Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more June 13, 2023 Tags Steel Dynamics Inc Biogen Inc Royal Caribbean Cruises Ltd From CNBC.com News FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval June 09, 2023 Tags U/S/ Economy Politics US Top News and Analysis From CNBC.com News < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.